Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

Eos Energy Enterprises Q1 Earnings Call Highlights

Eos Energy Enterprises (NASDAQ:EOSE) reported a sharp year-over-year increase in first-quarter revenue and outlined a new project financing platform that management said is intended to accelerate adoption of its long-duration energy storage systems. The company generated $57 million in first-quarte

Eastern Q1 Earnings Call Highlights

Eastern (NASDAQ:EML) reported lower first-quarter fiscal 2026 sales and earnings from continuing operations, as weaker demand for returnable transport packaging and an operating issue at its Big 3 Precision business weighed on margins. Management said improving order trends and sequential backlog gr

DarioHealth Q1 Earnings Call Highlights

DarioHealth (NASDAQ:DRIO) reported sequential revenue growth for the second straight quarter while outlining plans to expand its digital health platform further into care delivery, management said on the company’s first-quarter 2026 earnings call Wednesday. Chief Executive Officer Erez Raphael said

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

CTW Cayman H1 Earnings Call Highlights

CTW Cayman (NASDAQ:CTW) reported nearly flat revenue for the first half of fiscal 2026 while posting a GAAP net loss, as management said new game launches underperformed expectations and mature titles continued to age through their life cycles. On the company’s earnings call for the six months ende

Micron Investors Face a High-Stakes Moment After the Latest Rally

Micron's May peak is the signal for investors to raise capital in preparation for an upcoming entry point; catalysts include Q3 results scheduled for June.

How Bad Could Tesla’s Cybertruck Recall Be for Shares?

Tesla’s latest Cybertruck recall looks ugly at first glance, but investors remain far more focused on the company’s expanding AI and autonomy potential.

Compass Pathways Q1 Earnings Call Highlights

Compass Pathways (NASDAQ:CMPS) said it has begun a rolling New Drug Application submission for COMP360, its investigational psilocybin treatment for treatment-resistant depression, and is preparing for a potential launch by the end of the year if the therapy is approved. On the company’s first-quar

inkl

Read news from The Economist, FT, and more,
with one subscription

Brainsway Q1 Earnings Call Highlights

Brainsway (NASDAQ:BWAY) reported a strong start to 2026, with first-quarter revenue rising 35% year over year as the company expanded placements of its Deep TMS systems and continued to build its recurring revenue base. Chief Executive Officer Hadar Levy said on the company’s earnings call that rev

Applied Optoelectronics Eyes 800G Ramp as Data Center Demand Tops Capacity Into 2027

Applied Optoelectronics (NASDAQ:AAOI) expects a sharp second-half ramp in its data center optics business as demand for higher-speed transceivers continues to outstrip the company’s manufacturing capacity, Chief Strategy Officer and Chief Financial Officer Dr. Stefan Murry said at Needham’s 21st Ann

Bilfinger Q1 Earnings Call Highlights

Bilfinger (ETR:GBF) confirmed its 2026 outlook after reporting a slower start to the year, with management pointing to severe winter weather and geopolitical uncertainty as factors that delayed customer decisions and pressured operations in the first quarter. Group CEO Thomas Schulz said orders rec

Merck KGaA Q1 Earnings Call Highlights

Merck KGaA (ETR:MRK) reported what executives described as a “solid start” to 2026, with organic growth in its Life Science and Electronics businesses offsetting a decline in Healthcare, and raised its full-year outlook after stronger momentum late in the quarter. Group Chief Executive Officer Kai

Abeona Therapeutics Q1 Earnings Call Highlights

Abeona Therapeutics (NASDAQ:ABEO) reported early commercial momentum for ZEVASKYN in the first quarter of 2026, with executives highlighting new patient treatments, expanded treatment-center activation and a newly licensed prostate cancer cell therapy program during the company’s earnings call. Chi

Altimmune Q1 Earnings Call Highlights

Altimmune (NASDAQ:ALT) said it has strengthened its balance sheet and is preparing to begin a global Phase 3 trial of pemvidutide in metabolic dysfunction-associated steatohepatitis, or MASH, in the second half of 2026, as the company reported first-quarter financial results and provided updates acr

Brenntag Q1 Earnings Call Highlights

Brenntag (ETR:BNR) said its first-quarter 2026 results reflected a slow start to the year followed by a sharp improvement in March as volatility tied to the crisis in the Middle East lifted pricing and prompted some customers to rebuild inventories. On the company’s earnings call, Chief Operating O

Get all your
news in one place.

100's of premium titles.
One news app.

Humacyte Q1 Earnings Call Highlights

Humacyte (NASDAQ:HUMA) reported first-quarter 2026 Symvess sales of $0.5 million and outlined a series of commercial, clinical and cost-reduction initiatives aimed at accelerating adoption of its bioengineered vascular products. On the company’s earnings call, President and Chief Executive Officer

Deutsche Telekom Q1 Earnings Call Highlights

Deutsche Telekom (ETR:DTE) reported what Chief Executive Tim Höttges called a “robust” start to 2026, citing broad-based growth across the group and an upgraded full-year outlook following stronger guidance from T-Mobile US. On the company’s first-quarter earnings call, Höttges said group organic s

RWE Aktiengesellschaft Q1 Earnings Call Highlights

RWE Aktiengesellschaft (ETR:RWE) reported a stronger first quarter for fiscal 2026, with Chief Financial Officer Michael Müller telling analysts that the company had a “good start” to the year and was increasingly confident in meeting its full-year targets. Müller said adjusted EBITDA rose 25% year

MLP Q1 Earnings Call Highlights

MLP (ETR:MLP) reported record first-quarter revenue and earnings for 2026, with Chief Financial Officer Reinhard Loose saying the financial services group remained on its medium-term growth path despite market volatility and macroeconomic uncertainty. On the company’s earnings call, Loose said tota

Get all your
news in one place.

100's of premium titles.
One news app.

Atour Lifestyle Q1 Earnings Call Highlights

Atour Lifestyle (NASDAQ:ATAT) reported sharply higher first-quarter revenue for 2026, driven by continued expansion of its hotel network and strong growth in its retail business, while management said China’s hotel market is continuing a “moderate recovery” with a shift toward quality and differenti

Dream Finders Homes’ Hostile Bid Creates a Dual Squeeze Play

Dream Finders Homes is making an aggressive all-cash bid for Beazer Homes, a catalyst that may unlock value and signal further sector consolidation.

Why OpenAI’s IPO Plans Could Be a Massive Win for Microsoft

Microsoft’s OpenAI investment may now be worth over $228 billion after OpenAI’s restructuring and IPO plans. Here’s what it means for MSFT stock and AI growth.

A Real Biggie Deal: Wendy's Serves Up a Juicy Buyout Arbitrage

Wendy's is at the center of a potential private equity buyout, with its attractive dividend yield and turnaround plan creating a compelling investment case.

Orion Q1 Earnings Call Highlights

Orion (NYSE:OEC) raised its full-year earnings outlook after reporting first-quarter adjusted EBITDA that exceeded internal expectations, as management cited stronger demand late in the quarter and ongoing benefits from the company’s regional manufacturing footprint amid volatile energy markets and

Oklo Q1 Earnings Call Highlights

Oklo (NYSE:OKLO) reported a wider first-quarter 2026 loss as the advanced nuclear developer said it is moving further into asset deployment across its power, fuel and isotope businesses. Co-founder and Chief Executive Officer Jacob DeWitte told investors that the company has shifted “from strategy

Once Upon A Farm Q1 Earnings Call Highlights

Once Upon A Farm (NYSE:OFRM) raised its full-year revenue outlook after reporting first-quarter fiscal 2026 sales growth of nearly 44%, driven by higher volumes, expanded distribution and stronger demand across its baby products business. Chief Executive Officer and Co-founder John Foraker said the

1 … 56 57 58 59

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Prostate Cancer

Places

384,675 stories

the Middle East

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play